|
US3202654A
(en)
|
1962-04-27 |
1965-08-24 |
Bristol Myers Co |
6-[alpha-hydroxy-and alpha-amino-alpha-pyrrolylacetamido] penicillanic acids and salts thereof
|
|
GB1051723A
(enExample)
|
1962-04-27 |
|
|
|
|
US3252970A
(en)
|
1963-02-27 |
1966-05-24 |
Ciba Geigy Corp |
Aromatization
|
|
BE631632A
(enExample)
|
1963-04-26 |
|
|
|
|
US3268558A
(en)
|
1964-11-05 |
1966-08-23 |
Ortho Pharma Corp |
1-r-2, 4-dinitropyrroles
|
|
US3458515A
(en)
|
1966-07-21 |
1969-07-29 |
American Home Prod |
Piperazine substituted pyrroles
|
|
GB1208014A
(en)
|
1967-03-23 |
1970-10-07 |
Glaxo Lab Ltd |
Cephalosporins
|
|
US3573294A
(en)
|
1968-03-14 |
1971-03-30 |
Glaxo Lab Ltd |
7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives
|
|
BE790747A
(fr)
|
1971-10-30 |
1973-02-15 |
Whitefin Holding Sa |
Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
|
|
GB1476503A
(en)
|
1973-06-21 |
1977-06-16 |
Sterling Drug Inc |
1-arylamino-and 1-arylimino-pyrroles and preparation thereof
|
|
BE848465A
(fr)
|
1976-11-18 |
1977-03-16 |
|
Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
|
|
US4316900A
(en)
|
1977-10-05 |
1982-02-23 |
Ciba-Geigy Corporation |
Piperazinopyrrolobenzodiazepines
|
|
JPS57142966A
(en)
|
1981-02-27 |
1982-09-03 |
Sagami Chem Res Center |
(1-alkyl-2-pyrrolyl)glyoxylic acid amide derivative
|
|
JPS57144255A
(en)
|
1981-03-03 |
1982-09-06 |
Sagami Chem Res Center |
Alpha-methylthio(1-alkyl-2-pyrrolyl)acetamide derivative
|
|
US4761424A
(en)
|
1985-10-01 |
1988-08-02 |
Warner-Lambert Company |
Enolamides, pharmaceutical compositions and methods for treating inflammation
|
|
FR2601368B1
(fr)
|
1986-07-08 |
1989-04-07 |
Synthelabo |
Derives de nitrofuranne, leur preparation et leur application en therapeutique.
|
|
AU650953B2
(en)
|
1991-03-21 |
1994-07-07 |
Novartis Ag |
Inhaler
|
|
US5637592A
(en)
|
1994-07-12 |
1997-06-10 |
Janssen Pharmaceutica N.V. |
Acyl derivatives of azolones
|
|
BR9508298A
(pt)
|
1994-07-21 |
1998-11-03 |
Shionogi & Co |
Inibidores de indolizina de spla2
|
|
EP0823423B1
(en)
|
1995-04-28 |
2004-06-16 |
Banyu Pharmaceutical Co., Ltd. |
1,4-disubstituted piperidine derivatives
|
|
DE69517160T2
(de)
|
1995-06-06 |
2000-11-16 |
Agfa-Gevaert N.V., Mortsel |
Photographische Materialien
|
|
JPH09249669A
(ja)
|
1996-03-13 |
1997-09-22 |
Ono Pharmaceut Co Ltd |
縮合ピロール誘導体、およびそれらを有効成分として含有する薬剤
|
|
WO1998056422A1
(en)
|
1997-06-13 |
1998-12-17 |
The University Of Kansas |
Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
|
|
DK0901786T3
(da)
|
1997-08-11 |
2007-10-08 |
Pfizer Prod Inc |
Faste farmaceutiske dispersioner med foröget biotilgængelighed
|
|
IL140042A0
(en)
|
1998-06-03 |
2002-02-10 |
Guilford Pharm Inc |
Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
|
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
|
ATE404178T1
(de)
|
1999-02-10 |
2008-08-15 |
Pfizer Prod Inc |
Vorrichtung mit matrixgesteuerter wirkstofffreisetzung
|
|
ES2194723T3
(es)
|
1999-05-04 |
2003-12-01 |
Janssen Pharmaceutica Nv |
Eteres antifungicos.
|
|
WO2001008572A1
(de)
|
1999-07-30 |
2001-02-08 |
Norbert Heske |
Kanülenanordnung zum einbringen endoskopischer instrumente in einen menschlichen oder tierischen körper
|
|
DZ3227A1
(fr)
|
1999-12-23 |
2001-07-05 |
Pfizer Prod Inc |
Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
|
|
GB0011089D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Gastrin and cholecystokinin receptor ligands (11)
|
|
US7202239B2
(en)
|
2001-04-12 |
2007-04-10 |
Wyeth |
Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
|
|
US6825201B2
(en)
|
2001-04-25 |
2004-11-30 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic amidopiperazine derivatives
|
|
WO2002098876A1
(en)
|
2001-06-06 |
2002-12-12 |
Vertex Pharmaceuticals Incorporated |
Cak inhibitors and uses thereof
|
|
RU2319699C2
(ru)
|
2001-06-20 |
2008-03-20 |
Дайити Санкио Компани, Лимитед |
Производные диаминов
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
KR100664822B1
(ko)
|
2002-02-01 |
2007-01-04 |
화이자 프로덕츠 인코포레이티드 |
변형된 분무-건조 장치를 이용한 균질한 분무-건조된 고체비결정성 약물 분산액의 제조 방법
|
|
JP2005523260A
(ja)
|
2002-02-01 |
2005-08-04 |
ファイザー・プロダクツ・インク |
圧力ノズルを用いた均質噴霧乾燥固体非晶質薬剤分散体の製造方法
|
|
WO2003072028A2
(en)
|
2002-02-23 |
2003-09-04 |
Bristol-Myers Squibb Company |
Method of treating hiv infection by preventing interaction of cd4 and gp120
|
|
AU2003257791A1
(en)
|
2002-08-15 |
2004-03-29 |
Tong Liu |
Soild nano pharmaceutical formulation and preparation method thereof
|
|
US20050032871A1
(en)
|
2002-09-03 |
2005-02-10 |
Sugen, Inc. |
Sulfonylated pyrrole-2-indolinone derivatives as kinase inhibitors
|
|
CA2517034A1
(en)
|
2003-03-13 |
2004-09-30 |
Synta Pharmaceuticals Corp. |
Fused pyrrole compounds
|
|
FR2854079B1
(fr)
|
2003-04-25 |
2007-11-30 |
Pf Medicament |
Procede de preparation de complexes moleculaires
|
|
CL2004001884A1
(es)
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
US7105563B2
(en)
|
2003-10-24 |
2006-09-12 |
Schering Aktiengesellschaft |
Indolinone derivatives and their use in treating disease-states such as cancer
|
|
MXPA06013891A
(es)
|
2004-05-28 |
2007-01-26 |
Pfizer Prod Inc |
Composiciones farmaceuticas con comportamiento potenciado.
|
|
US20060058286A1
(en)
|
2004-09-16 |
2006-03-16 |
Mark Krystal |
Methods of treating HIV infection
|
|
EP2548894A1
(en)
|
2005-02-03 |
2013-01-23 |
Bend Research, Inc. |
Pharmaceutical compositions with enhanced performance
|
|
US7842810B2
(en)
|
2005-03-31 |
2010-11-30 |
Janssen Pharmaceutica, Nv |
Bicyclic pyrazole compounds as antibacterial agents
|
|
AR053713A1
(es)
|
2005-04-20 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos como agentes terapeuticos
|
|
EP1888063B1
(en)
|
2005-05-18 |
2009-01-14 |
F2G Ltd. |
Antifungal agents
|
|
JP2009501721A
(ja)
|
2005-07-12 |
2009-01-22 |
アカディア ファーマシューティカルズ インコーポレイテッド |
レチノイン酸受容体における活性を伴う化合物
|
|
WO2007015866A2
(en)
|
2005-07-20 |
2007-02-08 |
Kalypsys, Inc. |
Inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
KR20140107691A
(ko)
|
2006-03-20 |
2014-09-04 |
버텍스 파마슈티칼스 인코포레이티드 |
의약 조성물
|
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
|
US20080118500A1
(en)
|
2006-11-16 |
2008-05-22 |
Taiwan Liposome Company |
Sustained releasing composition via local injection for treating eye diseases
|
|
GB0623209D0
(en)
|
2006-11-21 |
2007-01-03 |
F2G Ltd |
Antifungal agents
|
|
US10189957B2
(en)
|
2007-01-26 |
2019-01-29 |
Isp Investments Llc |
Formulation process method to produce spray dried products
|
|
CN101260086B
(zh)
|
2007-03-06 |
2011-08-10 |
中国科学院上海药物研究所 |
蛋白酪氨酸磷酸酯酶1b抑制剂及其制备方法和用途
|
|
GB0710121D0
(en)
|
2007-05-25 |
2007-07-04 |
F2G Ltd |
Antifungal agents
|
|
EP2178518A2
(en)
|
2007-07-13 |
2010-04-28 |
Bend Research, Inc |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
JP5657524B2
(ja)
|
2008-04-24 |
2015-01-21 |
エフツージー リミテッド |
ピロール抗真菌剤
|
|
GB0809773D0
(en)
|
2008-05-29 |
2008-07-09 |
F2G Ltd |
Antifungal combination therapy
|
|
US20100093872A1
(en)
|
2008-10-15 |
2010-04-15 |
Erimos Pharmaceuticals Llc |
Stable aqueous formulations of water insoluble or poorly soluble drugs
|
|
JP2012525403A
(ja)
|
2009-04-28 |
2012-10-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ＰＫＣθ阻害薬による免疫学的疾患のＥＸ−ＶＩＶＯ治療
|
|
JP5792807B2
(ja)
|
2010-06-14 |
2015-10-14 |
ダウ グローバル テクノロジーズ エルエルシー |
アセテートおよびサクシネートの置換が向上されたヒドロキシプロピルメチルセルロースアセテートサクシネート
|
|
EP2611529B1
(en)
|
2010-09-03 |
2019-01-23 |
Bend Research, Inc. |
Spray-drying method
|
|
US20130288956A1
(en)
|
2010-11-05 |
2013-10-31 |
Eisai R&D Management Co., Ltd. |
Combined pharmaceutical composition as antifungal agent
|
|
CA2778748A1
(en)
|
2011-06-01 |
2012-12-01 |
Nitto Denko Corporation |
Particulate preparation and method for producing the same
|
|
BR112014012985B1
(pt)
|
2011-11-29 |
2020-05-12 |
Jurox Pty Ltd |
Composição farmacêutica injetável, seu método de produção e uso, bem como método de conservação de uma composição farmacêutica injetável e uso de pelo menos um co-solvente e pelo menos um conservante
|
|
WO2013154607A1
(en)
|
2012-04-11 |
2013-10-17 |
Dow Global Technologies Llc |
Esterified cellulose ethers having a specific substituent distribution
|
|
CN104981483B
(zh)
|
2012-08-24 |
2017-10-24 |
陶氏环球技术有限责任公司 |
新的羟烷基甲基醋酸琥珀酸纤维素
|
|
US9745387B2
(en)
|
2012-08-24 |
2017-08-29 |
Dow Global Technologies Llc |
Partially cross-linked esterified cellulose ethers
|
|
SG11201504499VA
(en)
|
2013-01-22 |
2015-08-28 |
Hoffmann La Roche |
Pharmaceutical composition with improved bioavailability
|
|
WO2015007759A1
(en)
|
2013-07-19 |
2015-01-22 |
Boehringer Ingelheim Vetmedica Gmbh |
Etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
|
|
DK3021832T3
(da)
|
2013-07-19 |
2021-05-25 |
Boehringer Ingelheim Vetmedica Gmbh |
Konserverede etherificerede cyclodextrinderivater indeholdende flydende vandig farmaceutisk sammensætning
|
|
EP3076951B1
(en)
|
2013-12-05 |
2020-09-30 |
Celal Albayrak |
Process for the production of drug formulations for oral administration
|
|
PT107568B
(pt)
|
2014-03-31 |
2018-11-05 |
Hovione Farm S A |
Processo de secagem por atomização para a produção de pós com propriedades melhoradas.
|
|
AU2015348043B2
(en)
*
|
2014-11-21 |
2019-08-22 |
F2G Limited |
Antifungal agents
|
|
GB201609222D0
(en)
*
|
2016-05-25 |
2016-07-06 |
F2G Ltd |
Pharmaceutical formulation
|